Skip to main content
. Author manuscript; available in PMC: 2020 Nov 12.
Published in final edited form as: J Alzheimers Dis. 2020;75(4):1241–1252. doi: 10.3233/JAD-200232

Table 3.

Relation of diabetes status categories (normal glucose tolerance [NGT], pre-diabetes, type 2 diabetes [T2D]), and of glycemia ascertained as hemoglobin A1c (HbA1c), with high global brain amyloid level by the median standardized uptake value ratio (SUVR). Odds ratios (OR) and 95% confidence intervals (CI) estimated defined by multinomial logistic regression. ORs report the odds of high vs. low amyloid defined by the median SUVR. Model 1 is unadjusted; Model 2 is adjusted for age, sex, and APOE-ε4; Model 3 is adjusted for lipids, body mass index, and differences in medication. For analyses with diabetes categories, NGT is the reference category.

Model 1 Model 2 Model 3
High Amyloid OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Type 2 diabetes categories
NGT 65 1.0 1.0 1.0
Pre-diabetes 58 1.57 (0.94, 2.64) 0.087 1.78 (1.01, 3.13) 0.045 1.60 (0.89, 2.86) 0.12
T2D 52 1.00 (0.61, 1.69) 0.99 1.06 (0.61, 1.84) 0.84 1.00 (0.43, 2.34) 0.99
P (global) 0.17 0.10 0.25
Hemoglobin A1c (HbA1c)
HbA1c 175 0.94 (0.80, 1.10) 0.46 0.99 (0.83, 1.18) 0.91 0.94 (0.73, 1.22) 0.66